Abstract Details

Title DI-CMTC: Dominant Intermediate Charcot-Marie-Tooth Disease Type C. A Neurophysiologic Study of 2 Families in Bulgaria and the USA

Topic

Presentation(s)

Poster/Presentation
Number 140

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Suneel K. Gupta, PhD	No disclosure on file
Cassie Jia	No disclosure on file
	No disclosure on file
Alexandra J. Sequeira, MD	Dr. Sequeira has nothing to disclose.
	No disclosure on file
Sherron H. Kell, MD (Impax Laboratories, Inc.)	No disclosure on file
Robert P. Rubens, MD, MBA, FAAN (NeuroDevMA Consulting, Inc.)	Dr. Rubens has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Rubens has received stock or an ownership interest from Takeda Pharmaceuticals.
	No disclosure on file